Literature DB >> 19717351

PARP inhibition during alkylation-induced genotoxic stress signals a cell cycle checkpoint response mediated by ATM.

Michael J Carrozza1, Donna F Stefanick, Julie K Horton, Padmini S Kedar, Samuel H Wilson.   

Abstract

By limiting cell cycle progression following detection of DNA damage, checkpoints are critical for cell survival and genome stability. Methylated DNA damage, when combined with inhibition of PARP activity, results in an ATR-dependent S phase delay of the cell cycle. Here, we demonstrate that another checkpoint kinase, ATM, also is involved in the DNA damage response following treatment with a sub-lethal concentration of MMS combined with the PARP inhibitor 4-AN. Both ATM and PARP activities are important for moderating cellular sensitivity to MMS. Loss of ATM activity, or that of its downstream effector Chk2, limited the duration of the S phase delay. The combination of MMS and 4-AN resulted in ATM and Chk2 phosphorylation and the time course of phosphorylation for both kinases correlated with the S phase delay. Chk2 phosphorylation was reduced in the absence of ATM activity. The Chk2 phosphorylation that remained in the absence of ATM appeared to be dependent on ATR and DNA-PK. The results demonstrate that, following initiation of base excision repair and inhibition of PARP activity, ATM activation is critical for preventing the cell from progressing through S phase, and for protection against MMS-induced cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19717351      PMCID: PMC2763951          DOI: 10.1016/j.dnarep.2009.07.010

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  51 in total

Review 1.  Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy.

Authors:  Jean-François Haince; Michèle Rouleau; Michael J Hendzel; Jean-Yves Masson; Guy G Poirier
Journal:  Trends Mol Med       Date:  2005-09-08       Impact factor: 11.951

2.  Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.

Authors:  Ian Hickson; Yan Zhao; Caroline J Richardson; Sharon J Green; Niall M B Martin; Alisdair I Orr; Philip M Reaper; Stephen P Jackson; Nicola J Curtin; Graeme C M Smith
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

3.  ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks.

Authors:  Ali Jazayeri; Jacob Falck; Claudia Lukas; Jiri Bartek; Graeme C M Smith; Jiri Lukas; Stephen P Jackson
Journal:  Nat Cell Biol       Date:  2005-12-04       Impact factor: 28.824

Review 4.  Importance of poly(ADP-ribose) polymerases in the regulation of DNA-dependent processes.

Authors:  E Petermann; C Keil; S L Oei
Journal:  Cell Mol Life Sci       Date:  2005-04       Impact factor: 9.261

5.  Regulation of CHK2 by DNA-dependent protein kinase.

Authors:  Jia Li; David F Stern
Journal:  J Biol Chem       Date:  2005-01-24       Impact factor: 5.157

6.  Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure.

Authors:  Julie K Horton; Donna F Stefanick; Jana M Naron; Padmini S Kedar; Samuel H Wilson
Journal:  J Biol Chem       Date:  2005-02-07       Impact factor: 5.157

Review 7.  Targeting chk2 kinase: molecular interaction maps and therapeutic rationale.

Authors:  Yves Pommier; Olivier Sordet; V Ashutosh Rao; Hongliang Zhang; Kurt W Kohn
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

8.  Complex H2AX phosphorylation patterns by multiple kinases including ATM and DNA-PK in human cells exposed to ionizing radiation and treated with kinase inhibitors.

Authors:  Hongyan Wang; Minli Wang; Huichen Wang; Wilfried Böcker; George Iliakis
Journal:  J Cell Physiol       Date:  2005-02       Impact factor: 6.384

9.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.

Authors:  Helen E Bryant; Niklas Schultz; Huw D Thomas; Kayan M Parker; Dan Flower; Elena Lopez; Suzanne Kyle; Mark Meuth; Nicola J Curtin; Thomas Helleday
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

10.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Authors:  Hannah Farmer; Nuala McCabe; Christopher J Lord; Andrew N J Tutt; Damian A Johnson; Tobias B Richardson; Manuela Santarosa; Krystyna J Dillon; Ian Hickson; Charlotte Knights; Niall M B Martin; Stephen P Jackson; Graeme C M Smith; Alan Ashworth
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

View more
  11 in total

1.  Increased PARP-1 association with DNA in alkylation damaged, PARP-inhibited mouse fibroblasts.

Authors:  Padmini S Kedar; Donna F Stefanick; Julie K Horton; Samuel H Wilson
Journal:  Mol Cancer Res       Date:  2012-01-13       Impact factor: 5.852

2.  Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.

Authors:  Michelle L Heacock; Donna F Stefanick; Julie K Horton; Samuel H Wilson
Journal:  DNA Repair (Amst)       Date:  2010-06-22

3.  The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.

Authors:  Somaira Nowsheen; James A Bonner; Eddy S Yang
Journal:  Radiother Oncol       Date:  2011-06-28       Impact factor: 6.280

4.  Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition.

Authors:  Julie K Horton; Donna F Stefanick; Jennifer Y Zeng; Michael J Carrozza; Samuel H Wilson
Journal:  DNA Repair (Amst)       Date:  2010-12-03

Review 5.  Base excision repair and design of small molecule inhibitors of human DNA polymerase β.

Authors:  Samuel H Wilson; William A Beard; David D Shock; Vinod K Batra; Nisha A Cavanaugh; Rajendra Prasad; Esther W Hou; Yuan Liu; Kenjiro Asagoshi; Julie K Horton; Donna F Stefanick; Padmini S Kedar; Michael J Carrozza; Aya Masaoka; Michelle L Heacock
Journal:  Cell Mol Life Sci       Date:  2010-09-16       Impact factor: 9.261

6.  E1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factor.

Authors:  Roberta L Turner; John C Wilkinson; David A Ornelles
Journal:  Virology       Date:  2014-04-15       Impact factor: 3.616

7.  Environmentally Relevant Concentrations of Arsenite Induce Dose-Dependent Differential Genotoxicity Through Poly(ADP-Ribose) Polymerase Inhibition and Oxidative Stress in Mouse Thymus Cells.

Authors:  Huan Xu; Xixi Zhou; Xia Wen; Fredine T Lauer; Ke Jian Liu; Laurie G Hudson; Lauren M Aleksunes; Scott W Burchiel
Journal:  Toxicol Sci       Date:  2015-10-05       Impact factor: 4.849

8.  Poly (ADP-ribose) polymerase inhibitor, an effective radiosensitizer in lung and pancreatic cancers.

Authors:  Kedar Hastak; Steven Bhutra; Renate Parry; James M Ford
Journal:  Oncotarget       Date:  2017-04-18

9.  Suicidal cross-linking of PARP-1 to AP site intermediates in cells undergoing base excision repair.

Authors:  Rajendra Prasad; Julie K Horton; Paul D Chastain; Natalie R Gassman; Bret D Freudenthal; Esther W Hou; Samuel H Wilson
Journal:  Nucleic Acids Res       Date:  2014-04-25       Impact factor: 16.971

10.  Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD Samples.

Authors:  Laura N Puentes; Zsofia Lengyel-Zhand; Ji Youn Lee; Chia-Ju Hsieh; Mark E Schneider; Kimberly J Edwards; Kelvin C Luk; Virginia M-Y Lee; John Q Trojanowski; Robert H Mach
Journal:  Front Aging Neurosci       Date:  2021-06-18       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.